ERBB2 and breast carcinoma: Based on the results from our current and past studies, we propose a hypothetical model of the TME in HER2 + breast cancer to explain the potential mechanisms behind the favorable prognosis of patients with HER2 + breast cancer, which is responsible for the high serum levels of miR-19a-3p (Fig. 5).